Medical marijuana has been one of the most effective and versatile treatments for a variety of diseases for decades. Recently, a number of U.S. states added new conditions to their lists of acceptable illnesses to receive such treatments. In Minnesota, sleep apnea patients can now turn to medical marijuana. Michigan also updated its list to include an additional 11 health issues such as autism.
After soliciting public comments as well as reviewing the scientific evidence on hand, the Minnesota Department of Health decided to allow medical marijuana as a treatment for sleep apnea, KSTP reports. This decision was also made after a review panel by citizens was hosted to ensure that the local populace was onboard.
However, not everyone is thrilled about this decision, with some health experts stating that medical marijuana is not as effective in treating the condition as conventional medical treatments. Sleep apnea expert Dr. Jonathan Parker is one such voice to express concern that the development could lead to negative consequences.
Aside from Minnesota, Michigan also decided to update its list of acceptable medical conditions that could receive medical marijuana treatment. These conditions include Parkinson’s disease, chronic pain, and Tourette’s syndrome, the Detroit Free Press reports. The state even threw in autism into the mix for good measure.
In order to make use of medical marijuana, however, patients will need a medical marijuana card. The card must be approved by a doctor and will cost $60.
With these new diseases on the list, the items have now gone up to 22 acceptable ailments. However, even as the state approved the 11 health conditions, it also rejected 11 others. The diseases that were not deemed acceptable to receive medical marijuana treatment include depression, panic attacks, and asthma. That last part might have been the most understandable, however, since it is a respiratory condition.


FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
Vanda Pharmaceuticals (VNDA) Stock Soars After FDA Approves BYSANTI for Bipolar I and Schizophrenia
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
CDC Acting Director Urges Measles Vaccination as U.S. Cases Surge in 2026
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
RFK Jr. Faces Scrutiny Over David Geier’s HHS Role and Vaccine Review Work
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Is dark chocolate healthier than milk chocolate? 2 dietitians explain 



